Use of Glucagon-Like Peptide-1 Receptor Agonists Does Not Increase the Risk of Cancer in Patients with Type 2 Diabetes Mellitus
There was a 73% higher risk of cancer in patients with T2DM compared with the general population. However, among patients with T2DM, there was no association between the use of GLP-1 RAs and new-onset cancers, including pancreatic and medullary thyroid cancers.
Authors
- Jinmi Kim (ORCID: https://orcid.org/0000-0002-6715-0447)
- Mijin Kim (ORCID: https://orcid.org/0000-0002-1538-8859)
- Bo Hyun Kim (ORCID: https://orcid.org/0000-0001-9632-9457)
- Seung Chan Kim (ORCID: https://orcid.org/0000-0001-7625-0848)
Institutions
- Pusan National University Hospital (KR)
- Pusan National University (KR)
Publication Details
- Journal
- Diabetes & Metabolism Journal
- Published
- 2024-10-24
- DOI
- https://doi.org/10.4093/dmj.2024.0105
- Citations
- 17
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 6.08
Funders
- Pusan National University
- Pusan National University Hospital